• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体间充质干细胞促进系统性硬化症缺血肢体再血管化:病例报告。

Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report.

机构信息

Azienda Ospedaliero-Universitaria Careggi and University of Florence, Florence, Italy.

出版信息

Ann Intern Med. 2010 Nov 16;153(10):650-4. doi: 10.7326/0003-4819-153-10-201011160-00007.

DOI:10.7326/0003-4819-153-10-201011160-00007
PMID:21079220
Abstract

BACKGROUND

Mesenchymal stem cells can differentiate into endothelial cells and participate in angiogenesis in adults. In experimental models of acute myocardial infarction, mesenchymal stem cells led to the recovery of cardiac function through the formation of a new vascular network.

OBJECTIVE

To describe treatment with intravenous infusions of expanded autologous mesenchymal stem cells in 1 patient with critical limb ischemia due to systemic sclerosis.

DESIGN

Case report.

SETTING

The rheumatology unit at the University of Florence, Florence, Italy.

PATIENT

A woman, aged 34 years, with systemic sclerosis who developed acute gangrene of the upper and lower limbs.

INTERVENTION

3 intravenous pulses of expanded autologous mesenchymal stem cells.

MEASUREMENTS

Angiography, skin histopathology, and immunohistochemistry.

RESULTS

Areas of necrotic skin were reduced after the first mesenchymal stem-cell infusion. After the third infusion, angiography showed revascularization of the patient's extremities. Skin section analysis revealed cell clusters with tubelike structures, and angiogenic factors were strongly expressed.

LIMITATION

Causality cannot be established by a single case.

CONCLUSION

In patients with systemic sclerosis who have severe peripheral ischemia, intravenous infusion of expanded autologous mesenchymal stem cells may foster the recovery of the vascular network, restore blood flow, and reduce skin necrosis.

PRIMARY FUNDING SOURCE

Fondazione Cassa di Risparmio di Pistoia e Pescia (partial funding).

摘要

背景

间充质干细胞可以分化为内皮细胞,并在成体中参与血管生成。在急性心肌梗死的实验模型中,间充质干细胞通过形成新的血管网络导致心脏功能的恢复。

目的

描述对 1 例因系统性硬化症导致严重肢体缺血的患者进行静脉输注扩增自体间充质干细胞的治疗情况。

设计

病例报告。

地点

意大利佛罗伦萨大学风湿病科。

患者

1 例 34 岁女性,患有系统性硬化症,出现上下肢急性坏疽。

干预措施

3 次静脉输注扩增自体间充质干细胞。

测量

血管造影、皮肤组织病理学和免疫组织化学。

结果

第 1 次间充质干细胞输注后,坏死皮肤面积减少。第 3 次输注后,血管造影显示患者四肢的血管再通。皮肤切片分析显示细胞簇具有管状结构,血管生成因子强烈表达。

局限性

单例病例不能确定因果关系。

结论

在患有严重外周缺血的系统性硬化症患者中,静脉输注扩增自体间充质干细胞可能有助于恢复血管网络,恢复血流并减少皮肤坏死。

主要资金来源

皮斯托亚和佩斯卡拉储蓄银行基金会(部分资助)。

相似文献

1
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report.自体间充质干细胞促进系统性硬化症缺血肢体再血管化:病例报告。
Ann Intern Med. 2010 Nov 16;153(10):650-4. doi: 10.7326/0003-4819-153-10-201011160-00007.
2
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis.自体间充质干细胞促进系统性硬化症中缺血肢体的血管再生。
Ann Intern Med. 2011 Jul 5;155(1):65; author reply 65-6. doi: 10.7326/0003-4819-155-1-201107050-00013.
3
Netrin-1 with stem cells promote angiogenesis in limb ischemic rats.Netrin-1与干细胞共同促进肢体缺血大鼠的血管生成。
J Surg Res. 2014 Dec;192(2):664-9. doi: 10.1016/j.jss.2014.07.006. Epub 2014 Jul 5.
4
Angiogenic properties of mesenchymal stem cells in a mouse model of limb ischemia.间充质干细胞在肢体缺血小鼠模型中的血管生成特性。
Methods Mol Biol. 2014;1213:147-69. doi: 10.1007/978-1-4939-1453-1_13.
5
Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia.增强型人骨髓间充质干细胞治疗性血管生成在小鼠后肢缺血模型中的作用。
Regen Med. 2013 May;8(3):283-93. doi: 10.2217/rme.13.17.
6
Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.大鼠后肢缺血模型中间充质干细胞与单核细胞血管生成能力的比较。
Cardiovasc Res. 2005 Jun 1;66(3):543-51. doi: 10.1016/j.cardiores.2005.02.006. Epub 2005 Mar 2.
7
Comparison of treatments of peripheral arterial disease with mesenchymal stromal cells and mesenchymal stromal cells modified with granulocyte and macrophage colony-stimulating factor.比较间充质基质细胞和粒细胞巨噬细胞集落刺激因子修饰的间充质基质细胞治疗外周动脉疾病。
Cytotherapy. 2013 Jul;15(7):820-9. doi: 10.1016/j.jcyt.2013.02.014. Epub 2013 May 7.
8
Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction.自体体外扩增间充质干细胞治疗人类陈旧性心肌梗死。
Arch Iran Med. 2007 Oct;10(4):467-73.
9
Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis.自体祖细胞植入作为系统性硬化症中缺血性手指的一种新型治疗干预措施。
Rheumatology (Oxford). 2009 Jan;48(1):61-4. doi: 10.1093/rheumatology/ken407. Epub 2008 Nov 20.
10
Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels.牙髓基质来源的间充质基质/干细胞的促血管生成特性及其形成功能性血管的能力。
Int J Biochem Cell Biol. 2013 Mar;45(3):560-70. doi: 10.1016/j.biocel.2012.12.001. Epub 2012 Dec 12.

引用本文的文献

1
Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic Sclerosis.间充质干细胞衍生的外泌体与微小RNA:推动系统性硬化症的无细胞治疗
Cells. 2025 Jul 3;14(13):1018. doi: 10.3390/cells14131018.
2
Stem cell therapy in systemic sclerosis.系统性硬化症中的干细胞疗法。
Clin Rheumatol. 2025 Jul 2. doi: 10.1007/s10067-025-07557-y.
3
Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.基于间充质干细胞的治疗方法用于治疗自身免疫性相关的纤维性皮肤病——系统性硬化症和硬皮病移植物抗宿主病。
Stem Cell Res Ther. 2023 Dec 18;14(1):372. doi: 10.1186/s13287-023-03543-w.
4
Stem cell-based therapy for systemic sclerosis.基于干细胞的系统性硬化症治疗
Rheumatol Adv Pract. 2023 Nov 20;7(3):rkad101. doi: 10.1093/rap/rkad101. eCollection 2023.
5
Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis.间充质干细胞及其外泌体在系统性硬化症中的研究进展
Front Pharmacol. 2023 Aug 25;14:1263839. doi: 10.3389/fphar.2023.1263839. eCollection 2023.
6
Progress in research on mesenchymal stem cells and their extracellular vesicles for treating fibrosis in systemic sclerosis.间充质干细胞及其细胞外囊泡治疗系统性硬化症纤维化的研究进展
Clin Exp Med. 2023 Nov;23(7):2997-3009. doi: 10.1007/s10238-023-01136-8. Epub 2023 Jul 17.
7
Umbilical-Cord-Derived Mesenchymal Stromal Cells Modulate 26 Out of 41 T Cell Subsets from Systemic Sclerosis Patients.脐带间充质基质细胞调节系统性硬化症患者41个T细胞亚群中的26个。
Biomedicines. 2023 Apr 30;11(5):1329. doi: 10.3390/biomedicines11051329.
8
Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases.间充质干细胞治疗难治性炎症性和免疫性皮肤疾病的潜力。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2144667. doi: 10.1080/21645515.2022.2144667. Epub 2022 Nov 16.
9
Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.系统性硬化症的细胞治疗:从造血干细胞移植到创新方法。
Cells. 2022 Oct 24;11(21):3346. doi: 10.3390/cells11213346.
10
Cell Based Treatment of Autoimmune Diseases in Children.儿童自身免疫性疾病的细胞治疗
Front Pediatr. 2022 May 9;10:855260. doi: 10.3389/fped.2022.855260. eCollection 2022.